Patrick Rossignol Selected Research

Chronic Renal Insufficiency

11/2023	Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA).
2/2023	A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.
1/2023	Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.
1/2023	Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective.
11/2022	Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTs.
9/2022	Potassium management with finerenone: Practical aspects.
1/2022	The non-steroidal mineralocorticoid receptor antagonist finerenone is a novel therapeutic option for patients with Type 2 diabetes and chronic kidney disease.
10/2021	Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.
9/2021	Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy.
9/2021	Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick Rossignol Research Topics

Disease

150	Heart Failure 05/2024 - 05/2009
55	Hypertension (High Blood Pressure) 02/2023 - 01/2003
46	Fibrosis (Cirrhosis) 03/2024 - 07/2010
42	Myocardial Infarction 10/2023 - 10/2004
32	Chronic Renal Insufficiency 11/2023 - 10/2015
31	Inflammation (Inflammations) 11/2023 - 01/2010
31	Hyperkalemia 11/2023 - 11/2012
18	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 02/2012
18	Left Ventricular Dysfunction 04/2022 - 05/2009
16	Chronic Kidney Failure (Chronic Renal Failure) 05/2024 - 06/2013
13	Type 2 Diabetes Mellitus (MODY) 11/2023 - 10/2019
11	Thrombosis (Thrombus) 06/2021 - 11/2002
10	Diabetes Mellitus 01/2023 - 01/2014
9	Renal Insufficiency (Renal Failure) 01/2024 - 11/2012
9	Atrial Fibrillation 04/2022 - 01/2018
8	Hypokalemia 01/2023 - 04/2008
7	Kidney Diseases (Kidney Disease) 11/2023 - 12/2018
7	Albuminuria 11/2023 - 02/2012
7	Obesity 01/2022 - 08/2015
6	Respiratory Sounds (Crackle) 11/2022 - 11/2012
6	Stroke (Strokes) 02/2022 - 05/2014
6	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 08/2012
6	Acute Coronary Syndrome 01/2021 - 05/2014
6	Hyperaldosteronism (Conn Syndrome) 01/2018 - 04/2008
5	Atherosclerosis 01/2023 - 04/2016
5	Systolic Heart Failure 01/2021 - 11/2012
4	Hemorrhage 02/2022 - 06/2013
4	Hypertrophy 01/2022 - 06/2010
4	Neoplasms (Cancer) 01/2022 - 10/2004
4	Aneurysm (Aneurysms) 04/2011 - 11/2002
3	ST Elevation Myocardial Infarction 10/2023 - 01/2018
3	COVID-19 06/2023 - 10/2020
3	Weight Loss (Weight Reduction) 04/2022 - 11/2017
3	Body Weight (Weight, Body) 04/2022 - 11/2011
3	Isolated Systolic Hypertension 11/2021 - 04/2006
3	Anemia 01/2021 - 03/2012
3	Acute Kidney Injury (Acute Renal Failure) 02/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

54	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2006
44	Mineralocorticoid Receptor AntagonistsIBA 11/2023 - 05/2009
40	PotassiumIBA 09/2023 - 11/2011
36	Spironolactone (Aldactone)FDA LinkGeneric 03/2024 - 11/2012
34	Eplerenone (Inspra)FDA LinkGeneric 01/2023 - 05/2009
23	AldosteroneIBA 10/2023 - 04/2008
18	CollagenIBA 05/2024 - 08/2008
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2003
17	Galectin 3 (LGALS3)IBA 04/2023 - 01/2012
14	CreatinineIBA 09/2023 - 07/2014
14	Antihypertensive Agents (Antihypertensives)IBA 11/2021 - 04/2006
12	SodiumIBA 11/2023 - 06/2016
12	DiureticsIBA 09/2023 - 11/2011
11	Natriuretic PeptidesIBA 11/2023 - 01/2018
11	patiromerIBA 02/2023 - 01/2018
10	ReninIBA 01/2023 - 01/2002
9	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2023 - 01/2019
9	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 05/2009
8	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 11/2016
8	Angiotensin Receptor AntagonistsIBA 10/2023 - 03/2015
8	Procollagen Type IIBA 04/2023 - 11/2013
8	Collagen Type I (Type I Collagen)IBA 01/2023 - 05/2009
8	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 06/2021 - 05/2012
7	procollagen type I carboxy terminal peptide (PICP)IBA 04/2023 - 01/2019
7	AmberIBA 02/2023 - 01/2018
7	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2022 - 08/2008
7	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 08/2021 - 08/2013
6	Peptides (Polypeptides)IBA 04/2023 - 02/2010
6	SaltsIBA 01/2023 - 12/2011
6	Collagen Type III (Type III Collagen)IBA 01/2022 - 11/2013
6	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 05/2002
6	LectinsIBA 01/2018 - 01/2013
5	finerenoneIBA 11/2023 - 01/2022
5	AlbuminsIBA 09/2023 - 01/2018
5	AngiotensinsIBA 01/2023 - 03/2012
5	LipidsIBA 03/2022 - 01/2010
5	Hemoglobins (Hemoglobin)IBA 11/2020 - 02/2010
5	ElectrolytesIBA 10/2020 - 11/2016
5	Phenobarbital (Luminal)FDA Link 04/2011 - 11/2002
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2024 - 02/2013
4	Losartan (Cozaar)FDA LinkGeneric 01/2023 - 03/2015
4	C-Reactive ProteinIBA 06/2022 - 08/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2012
4	alogliptinIBA 07/2021 - 01/2020
4	Insulin (Novolin)FDA Link 01/2021 - 02/2019
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020 - 01/2002
4	CholesterolIBA 01/2020 - 01/2002
4	Angiotensin IIIBA 01/2018 - 01/2002
4	citrus pectinIBA 01/2016 - 01/2015
3	CytokinesIBA 11/2023 - 08/2008
3	TroponinIBA 01/2023 - 01/2021
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2022 - 03/2015
3	Interleukin-6 (Interleukin 6)IBA 06/2021 - 08/2012
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2003
3	Uric Acid (Urate)IBA 10/2020 - 11/2015

Therapy/Procedure

46	Therapeutics 01/2023 - 01/2002
15	Renal Dialysis (Hemodialysis) 05/2024 - 08/2012
7	Kidney Transplantation 04/2023 - 12/2017
6	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2024 - 05/2014
5	Denervation 01/2023 - 10/2015
3	Catheters 01/2023 - 02/2020
3	Length of Stay 01/2022 - 10/2018
3	Nephrectomy 01/2021 - 01/2002